Lung Transplantation Clinical Trial
Official title:
Vibration Response Imaging (VRI) in Lung Transplant Recipients
This study is a prospective, multi-center study. 50 lung transplant recipients will be enrolled in the study. Subjects will be selected from lung transplant recipients, who have undergone single or double lung transplantation during the last six months These patients will undergo a baseline VRI recording prior to the interventional procedure and a follow-up VRI at 1 hour after the interventional procedure. Furthermore, the patients will be recorded at the designated follow-up periods of 1, 3 and 6-month (+ 7 days) post-baseline visit, as well as before and 1 hour after any recurrent interventional procedure
- Study participants will be patients who have undergone lung transplantation during the
last 6 months and are in a stable clinical position at the time of enrollment.
- Patients who meet the study inclusion and exclusion criteria will be enrolled in the
study.
- The enrolled patients will be recorded with the VRI at each occurrence in which the
standard procedures are performed:
- Baseline after study enrollment (VRI Recording 1 + standard evaluations).
- At each follow-up visit [1, 3, 6 months after baseline visit] during the 6 month
follow-up period of the study (VRI Recordings + standard evaluations (if
possible)).
- In the event of bronchoscopic intervention, then before the interventional
procedure (VRI Recording 1 + standard evaluations) and before any recurrent
interventional procedures (VRI Recordings + standard evaluations) during the
course of the study (6-month follow-up period).
- 1 hour after all bronchoscopic interventional procedures.
- In the event of an unanticipated visit, then a VRI recording will be performed
(VRI Recordings + standard evaluations).
- All subjects will be recorded according to a standard procedure; moreover, it is
essential that for each subject repeatable recordings will be performed in the same
manner (i.e. breathing manner and matrix placement). Each VRI recording session will
take ~15 minutes [the actual recording is ~2 minutes for placement and
breathing/recording].
- Standard evaluation procedures may include any of the following:
- Lung function tests (this test is required at all visits)
- Physical examination
- Bronchoscopy (e.g. transbronchial biopsy)
- CT-imaging
- Chest x-ray
- V/Q Scan (Baseline visit for single lung transplantation)
- Blood gases (this test is required at all visits)
- Blood tests
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02581111 -
Naloxone for Optimizing Hypoxemia Of Lung Donors
|
Phase 2/Phase 3 | |
Recruiting |
NCT02177916 -
Patient Education Study to Determine Knowledge Acquisition in Patients Preparing to Undergo Lung Transplantation
|
N/A | |
Not yet recruiting |
NCT01394835 -
Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients
|
Phase 2 | |
Completed |
NCT01204970 -
Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients
|
N/A | |
Not yet recruiting |
NCT01162148 -
Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation
|
N/A | |
Active, not recruiting |
NCT00980967 -
Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study
|
N/A | |
Completed |
NCT00531921 -
Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival
|
N/A | |
Recruiting |
NCT00163696 -
Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease
|
N/A | |
Completed |
NCT00177684 -
Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
|
Phase 3 | |
Completed |
NCT00163891 -
Comparison of Two Chest Physiotherapy Protocols in Lung Transplant Recipients
|
N/A | |
Completed |
NCT03668483 -
Relation Between Muscle Strength With Exercise Capacity and Dyspnea in LTx
|
N/A | |
Not yet recruiting |
NCT02855372 -
Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)
|
N/A | |
Completed |
NCT01212406 -
Vitamin D in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
Completed |
NCT01211509 -
Montelukast in Bronchiolitis Obliterans Syndrome
|
Phase 4 | |
Not yet recruiting |
NCT00808600 -
Empowerment of Lung and Heart-lung Transplant Patients
|
N/A | |
Completed |
NCT00553397 -
Live Lung Donor Retrospective Study
|
N/A | |
Completed |
NCT00402805 -
Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
|
Phase 4 | |
Terminated |
NCT00235651 -
Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients
|
Phase 3 | |
Completed |
NCT00701922 -
Surveillance Study of Viral Infections Following Lung Transplantation
|
N/A | |
Active, not recruiting |
NCT02936505 -
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
|
N/A |